Ignite Creation Date:
2025-12-24 @ 7:35 PM
Ignite Modification Date:
2026-02-26 @ 11:04 AM
Study NCT ID:
NCT03100903
Status:
COMPLETED
Last Update Posted:
2025-10-16
First Post:
2017-03-31
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Safety, Tolerability, and Pharmacokinetics of a Subcutaneous and Intravenous Dose of BI 655130 in Healthy Subjects
Sponsor:
Boehringer Ingelheim
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2017-04-24
Start Date Type:
ACTUAL
Primary Completion Date:
2018-01-10
Primary Completion Date Type:
ACTUAL
Completion Date:
2018-01-10
Completion Date Type:
ACTUAL
First Submit Date:
2017-03-31
First Submit QC Date:
None
Study First Post Date:
2017-04-04
Study First Post Date Type:
ACTUAL
Results First Submit Date:
2022-09-26
Results First Submit QC Date:
None
Results First Post Date:
2024-03-18
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-10-08
Last Update Post Date:
2025-10-16
Last Update Post Date Type:
ESTIMATED